Erratum: Controversies in Corticosteroid use for Sepsis (The Journal of Emergency Medicine (2017) 53(5) (653–661) (S0736467917304705) (10.1016/j.jemermed.2017.05.024));Controversies in Corticosteroid use for Sepsis

Journal of Emergency Medicine

Volumn 53, Issue 5, 2017, Pages 653-661

  Long, Brit ^a   Koyfman, Alex ^b  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

corticosteroids; cosyntropin; HPA axis; hydrocortisone; septic shock; severe sepsis

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; VASOCONSTRICTOR AGENT;

ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INCIDENCE; INFECTION RISK; MORTALITY RATE; MULTICENTER STUDY (TOPIC); MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SECONDARY INFECTION; SEPTIC SHOCK; SURVIVAL TIME; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT; HOSPITAL EMERGENCY SERVICE; METABOLISM; ORGANIZATION AND MANAGEMENT; SEPSIS;

ADRENAL CORTEX HORMONES; EMERGENCY SERVICE, HOSPITAL; HUMANS; SEPSIS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 85029153611     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2017.12.051     Document Type: Erratum

References (68)

1. Elixhauser A, Friedman B, Stranges E. Septicemia in U.S. hospitals, 2009. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf. Accessed May 5, 2016.
2. Rhodes, A., Evans, L.E., Alhazzani, W., et al. Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock: 2016. Crit Care Med 45 (2017), 486–552.
3. Russell, J.A., Management of sepsis. N Engl J Med 355 (2006), 699–713.
4. Dombrovskiy, V.Y., Martin, A.A., Sunderram, J., Paz, H.L., Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35 (2007), 1244–1250.
5. Rivers, E., Nguyen, B., Havstad, S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001), 1368–1377.
6. ProCESS Investigators, Yealy, D.M., Kellum, J.A., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 370 (2014), 1683–1693.
7. ARISE Investigators Anzics Clinical Trials Group, Peake, S.L., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371 (2014), 1496–1506.
8. Mouncey, P.R., Osborn, T.M., Power, G.S., et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372 (2015), 1301–1311.
9. Nguyen, H.B., Jaehne, A.K., Jayaprakash, N., et al. Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care, 20, 2016, 160.
10. Remick, D.G., Pathophysiology of sepsis. Am J Pathol 170 (2007), 1435–1444.
11. Annane, D., Bellissant, E., Bollaert, P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301 (2009), 2362–2375.
12. Minneci, P.C., Deans, K.J., Eichacker, P.Q., Natanson, C., The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect 15 (2009), 308–318.
13. Minneci, P.C., Deans, K.J., Natanson, C., Corticosteroid therapy for severe sepsis and septic shock. JAMA, 302, 2009, 1643 author reply 1644.
14. Sligl, W.I., Milner, D.A. Jr., Sundar, S., et al. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49 (2009), 93–101.
15. Annane, D., Bellissant, E., Bollaert, P.E., Briegel, J., Keh, D., Kupfer, Y., Corticosteroids for treating sepsis. Cochrane Database Syst Rev, 2015, CD002243.
16. Lamberts, S.W., Bruining, H.A., de Jong, F.H., Corticosteroid therapy in severe illness. N Engl J Med 337 (1997), 1285–1292.
17. Cooper, M.S., Stewart, P.M., Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348 (2003), 727–734.
18. Newsome, H.H., Rose, J.C., The response of human adrenocorticotrophic hormone and growth hormone to surgical stress. J Clin Endocrinol Metab 33 (1971), 481–487.
19. Hume, D.M., Bell, C.C., Bartter, F., Direct measurement of adrenal secretion during operative trauma and convalescence. Surgery 52 (1962), 174–187.
20. Boonen, E., Vervenne, H., Meersseman, P., et al. Reduced cortisol metabolism during critical illness. N Engl J Med 368 (2013), 1477–1488.
21. Vadas, P., Pruzanski, W., Plasma cortisol levels in patients with septic shock. Crit Care Med 19 (1991), 300–301.
22. Beishuizen, A., Thijs, L.G., Vermes, I., Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27 (2001), 1584–1591.
23. Hammond, G.L., Smith, C.L., Paterson, N.A., Sibbald, W.J., A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab 71 (1990), 34–39.
24. Mesotten, D., Vanhorebeek, I., Van den Berghe, G., The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 4 (2008), 496–505.
25. Marik, P.E., Pastores, S.M., Annane, D., et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36 (2008), 1937–1949.
26. Balk, R.A., Steroids for septic shock: back from the dead? (Pro). Chest 123 (2003), 490S–499S.
27. McGee, S., Hirschmann, J., Use of corticosteroids in treating infectious diseases. Arch Intern Med 168 (2008), 1034–1046.
28. Schumer, W., Steroids in the treatment of clinical septic shock. Ann Surg 184 (1976), 333–341.
29. Shine, K.I., Kuhn, M., Young, L.S., Tillisch, J.H., Aspects of the management of shock. Ann Intern Med 93 (1980), 723–734.
30. Spink, W.W., ACTH and adrenocorticosteroids as therapeutic adjuncts in infectious diseases. N Engl J Med 257 (1957), 1031–1035.
31. Wagner, H.N. Jr., Bennett, I.L. Jr., Lasagna, L., et al. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 98 (1956), 197–215.
32. Kass, E.H., Adrenocorticosteroids and the management of infectious diseases. AMA Arch Intern Med 102 (1958), 1–4.
33. Bennett, I.L. Jr., Finland, M., Hamburger, M., The effectiveness of hydrocortisone in the management of severe infections. JAMA, 183, 1963, 462.
34. Bone, R.C., Fisher, C.J. Jr., Clemmer, T.P., Slotman, G.J., Metz, C.A., Balk, R.A., A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 (1987), 653–658.
35. Veterans Administration Systemic Sepsis Cooperative Study Group, Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317 (1987), 659–665.
36. Sprung, C.L., Caralis, P.V., Marcial, E.H., et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 311 (1984), 1137–1143.
37. Cronin, L., Cook, D.J., Carlet, J., et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23 (1995), 1430–1439.
38. Sessler, C.N., Steroids for septic shock: back from the dead? (Con). Chest 123 (2003), 482S–489S.
39. Carlet, J., From mega to more reasonable doses of corticosteroids: a decade to recreate hope. Crit Care Med 27 (1999), 672–674.
40. Bollaert, P.E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., Larcan, A., Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26 (1998), 645–650.
41. Briegel, J., Forst, H., Haller, M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27 (1999), 723–732.
42. Yildiz, O., Doganay, M., Aygen, B., Guven, M., Kelestimur, S., Tutuu, A., Physiological-dose steroid therapy in sepsis. Crit Care 6 (2002), 251–258.
43. Annane, D., Sebille, V., Charpentier, C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock. JAMA 288 (2002), 862–871.
44. Oppert, M., Schindler, R., Husung, C., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 (2005), 2457–2464.
45. Moran, J.L., Graham, P.L., Rockliff, S., Bersten, A.D., Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care, 14, 2010, R134.
46. Minneci, P.C., Deans, K.J., Banks, S.M., Eichacker, P.Q., Natanson, C., Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141 (2004), 47–56.
47. Keh, D., Sprung, C.L., Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review. Crit Care Med 32 (2004), S527–S533.
48. Sprung, C.L., Annane, D., Keh, D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008), 111–124.
49. Wang, C., Sun, J., Zheng, J., et al. Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials. Anesth Analg 118 (2014), 346–357.
50. Sherwin, R.L., Garcia, A.J., Bilkovski, R., Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 43 (2012), 7–12.
51. Gibbison, B., Lopez-Lopez, J.A., Higgins, J.P., et al. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care, 21, 2017, 78.
52. Patel, G.P., Balk, R.A., Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 185 (2012), 133–139.
53. Stanbury, R., Graham, E., Systemic corticosteroid therapy—side effects and their management. Br J Ophthalmol 82 (1998), 704–708.
54. Melby, J.C., Spink, W.W., Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection. J Clin Invest 37 (1958), 1791–1798.
55. Bouachour, G., Roy, P.M., Guiraud, M.P., The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med 123 (1995), 962–963.
56. Sibbald, W.J., Short, A., Cohen, M.P., Wilson, R.F., Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 186 (1977), 29–33.
57. Schein, R.M., Sprung, C.L., Marcial, E., et al. Plasma cortisol levels in patients with septic shock. Crit Care Med 18 (1990), 259–263.
58. Hamrahian, A.H., Oseni, T.S., Arafah, B.M., Measurements of serum free cortisol in critically ill patients. N Engl J Med 350 (2004), 1629–1638.
59. Moran, J.L., Chapman, M.J., O'Fathartaigh, M.S., et al. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 20 (1994), 489–494.
60. Rothwell, P.M., Udwadia, Z.F., Lawler, P.G., Cortisol response to corticotropin and survival in septic shock. Lancet 337 (1991), 582–583.
61. Marik, P.E., Zaloga, G.P., Adrenal insufficiency during septic shock. Crit Care Med 31 (2003), 141–145.
62. Siraux, V., De Backer, D., Yalavatti, G., et al. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit Care Med 33 (2005), 2479–2486.
63. Venkatesh, B., Mortimer, R.H., Couchman, B., Hall, J., Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study. Anaesth Intensive Care 33 (2005), 201–209.
64. Loisa, P., Uusaro, A., Ruokonen, E., A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock. Anesth Analg 101 (2005), 1792–1798.
65. Briegel, J., Sprung, C.L., Annane, D., et al. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 35 (2009), 2151–2156.
66. The COIITSS Study Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303 (2010), 341–348.
67. Venkatesh, B., Myburgh, J., Finfer, S., et al. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 15 (2013), 83–88.
68. Keh, D., Trips, E., Marx, G., et al., for the SepNet–Critical Care Trials Group. Effect of hydrocortisone on development of shock among patients with severe sepsis. The HYPRESS Randomized Clinical Trial. JAMA 316 (2016), 1775–1785.